See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Artificial Intelligence
Donald Trump
Social Media
Immigration
Stock Markets
Music
Housing
Nvidia
Natural Disasters
Republican Party
MLB
Inflation
Published • loading... • Updated

HKU launches clinical trial in Hong Kong to treat chronic hepatitis B patients

Summary by South China Morning Post
Existing medication only suppresses virus and has to be taken for decades, researcher says.

2 Articles

South China Morning PostSouth China Morning Post
Center

HKU launches clinical trial in Hong Kong to treat chronic hepatitis B patients

Existing medication only suppresses virus and has to be taken for decades, researcher says.

·Hong Kong
Read Full Article
ScienceDirectScienceDirect

Effect of tauroursodeoxycholic acid on serum liver enzyme and serum lipid levels in patients with chronic active hepatitis

Tauroursodeoxycholic acid (TUDCA) is a new natural bile acid amidate being investigated as a gallstone-dissolving agent in humans. We report herein th…

·Amsterdam, Netherlands
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

South China Morning Post broke the news in Hong Kong on Thursday, July 10, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Asia icon

Asia

Technology icon

Technology

Hepatitis B icon

Hepatitis B

Hong Kong City icon

Hong Kong City

News
For You
SearchBlindspotLocal